Chronic Myeloproliferative Disorders Completed Phase 1 / 2 Trials for Ifosfamide (DB01181)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003406Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerTreatment